Cargando…

CD169(+) Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, T(regs) and a Worse Prognosis for Patients with Advanced Breast Cancer

SIMPLE SUMMARY: We here show that CD169(+) TAMs in primary breast tumors are associated with tertiary lymphoid-like structures (TLLSs), T(reg) and B(reg) signatures, and a worse prognosis for the patient. In contrast, CD169(+) TAMs and TLLSs present in lymph node metastases were associated with bett...

Descripción completa

Detalles Bibliográficos
Autores principales:	Briem, Oscar, Källberg, Eva, Kimbung, Siker, Veerla, Srinivas, Stenström, Jenny, Hatschek, Thomas, Hagerling, Catharina, Hedenfalk, Ingrid, Leandersson, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954705/ https://www.ncbi.nlm.nih.gov/pubmed/36831605 http://dx.doi.org/10.3390/cancers15041262

Ejemplares similares

Breast cancer associated CD169(+) macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells
por: Gunnarsdottir, Frida Björk, et al.
Publicado: (2023)

Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
por: Stenström, Jenny, et al.
Publicado: (2021)

Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial
por: Feldt, Maria, et al.
Publicado: (2015)

Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial
por: Kimbung, Siker, et al.
Publicado: (2017)

How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
por: Saghir, Hani, et al.
Publicado: (2022)

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications
por: Kimbung, Siker, et al.
Publicado: (2015)

Molecular Subtyping of Serous Ovarian Tumors Reveals Multiple Connections to Intrinsic Breast Cancer Subtypes
por: Jönsson, Jenny-Maria, et al.
Publicado: (2014)

Infiltration of [Formula: see text] T cells, IL-17 [Formula: see text] T cells and FoxP3 [Formula: see text] T cells in human breast cancer
por: Allaoui, Roni, et al.
Publicado: (2018)

Insensitivity to atorvastatin is associated with increased accumulation of intracellular lipid droplets and fatty acid metabolism in breast cancer cells
por: Lettiero, Barbara, et al.
Publicado: (2018)

Afadin cooperates with Claudin-2 to promote breast cancer metastasis
por: Tabariès, Sébastien, et al.
Publicado: (2019)

High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer
por: Kimbung, Siker, et al.
Publicado: (2016)

Adipocytes and Obesity-Related Conditions Jointly Promote Breast Cancer Cell Growth and Motility: Associations With CAP1 for Prognosis
por: Rosendahl, Ann H., et al.
Publicado: (2018)

Co-localization of CD169(+) macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
por: Björk Gunnarsdottir, Frida, et al.
Publicado: (2020)

Complement inhibitor factor H expressed by breast cancer cells differentiates CD14(+) human monocytes into immunosuppressive macrophages
por: Smolag, Karolina I., et al.
Publicado: (2020)

Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study
por: Bjarnadottir, Olöf, et al.
Publicado: (2020)

High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
por: Inasu, Maria, et al.
Publicado: (2021)

Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study
por: Lawler, Katherine, et al.
Publicado: (2017)

High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer
por: Rennstam, Karin, et al.
Publicado: (2006)

A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
por: Leandersson, Pia, et al.
Publicado: (2020)

Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
por: Matikas, Alexios, et al.
Publicado: (2018)

The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
por: Medrek, Catharina, et al.
Publicado: (2012)

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
por: Kaminska, Kamila, et al.
Publicado: (2021)

The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer
por: Johansson, Ida, et al.
Publicado: (2013)

Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers
por: Haugen, Mads H., et al.
Publicado: (2021)

169. The Impact Of Silicone Breast Implant Shells On T Cells In Seroma-like Conditions
por: Corpuz, George S., et al.
Publicado: (2023)

Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
por: Allaoui, Roni, et al.
Publicado: (2016)

Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
por: Veerla, Srinivas, et al.
Publicado: (2023)

Worse and worse off: the impact of lymphedema on work and career after breast cancer
por: Boyages, John, et al.
Publicado: (2016)

CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
por: Kimbung, Siker, et al.
Publicado: (2020)

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
por: Staaf, Johan, et al.
Publicado: (2022)

The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer
por: Shiota, Takuya, et al.
Publicado: (2016)

High Levels of Expression of Cartilage Oligomeric Matrix Protein in Lymph Node Metastases in Breast Cancer Are Associated with Reduced Survival
por: Papadakos, Konstantinos S., et al.
Publicado: (2021)

Poster 169: Prior Rotator Cuff Repair Is Not Associated with Worse Outcomes After Subsequent Superior Capsular Reconstruction: A Comparative Analysis
por: Chao, Richard, et al.
Publicado: (2022)

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
por: Simonsson, Maria, et al.
Publicado: (2016)

Study of the disintegration of erbium 169
por: Charpak, Georges, et al.
Publicado: (1959)

169th AAS Meeting
Publicado: (1987)

169th RB Meeting
Publicado: (2004)

Subject index for volume 169
Publicado: (1989)

Statins: a role in breast cancer therapy?
por: Borgquist, S., et al.
Publicado: (2018)

RNA quality in frozen breast cancer samples and the influence on gene expression analysis – a comparison of three evaluation methods using microcapillary electrophoresis traces
por: Strand, Carina, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_buciu22h78r7h2i740rja5no2c